Education
About Us
Working with TipRanks
Follow Us
LakeShore Biopharma (LSBCF)
OTHER OTC:LSBCF
LSBCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.30 - $8.60
Previous CloseN/A
VolumeN/A
Average Volume (3M)80.98K
Market Cap
$30.71M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Jan 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,212,692
10 Day Avg. Volume171,434
30 Day Avg. Volume80,985
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LSBCF FAQ
What was LakeShore Biopharma’s price range in the past 12 months?
LakeShore Biopharma lowest stock price was $0.30 and its highest was $8.60 in the past 12 months.
What is LakeShore Biopharma’s market cap?
LakeShore Biopharma’s market cap is $30.71M.
When is LakeShore Biopharma’s upcoming earnings report date?
LakeShore Biopharma’s upcoming earnings report date is Jan 26, 2026 which is in 117 days.
How were LakeShore Biopharma’s earnings last quarter?
Currently, no data Available
Is LakeShore Biopharma overvalued?
According to Wall Street analysts LakeShore Biopharma’s price is currently Overvalued.
Does LakeShore Biopharma pay dividends?
LakeShore Biopharma does not currently pay dividends.
What is LakeShore Biopharma’s EPS estimate?
LakeShore Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LakeShore Biopharma have?
LakeShore Biopharma has 41,212,692 shares outstanding.
What happened to LakeShore Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LakeShore Biopharma?
Currently, no hedge funds are holding shares in LSBCF
LakeShore Biopharma Stock Smart Score
Company Description
LakeShore Biopharma
LakeShore Biopharma (LSB) is a leading biotechnology firm specializing in the research, development, and commercialization of innovative therapeutic solutions in the fields of oncology and autoimmune diseases. The company leverages advanced biopharmaceutical technologies to create novel drug candidates aimed at improving patient outcomes. LSB's portfolio includes a range of biologics and small molecule therapies, with a strong emphasis on precision medicine and personalized treatment regimens.
Technical Analysis
CASI Pharmaceuticals
―
Atara Biotherapeutics
―
NRX Pharmaceuticals
―
Werewolf Therapeutics
―
Radiopharm Theranostics Limited Sponsored ADR
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.39% Other Institutional Investors
99.61% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---